News 1 min read

CVS break-up shows how M&A-first strategy is not the healthiest option

By November 10, 2026

Despite touting better customer outcomes as well as major financial benefits, its stock price has underperformed

https://www.ft.com/content/373a5096-c8a8-44d2-830c-b9d8e0129c78?syn-25a6b1a6=1

Leave a Reply

Your email address will not be published. Required fields are marked *